Page 59 - Read Online

Aydin et al. J Transl Genet Genom. 2025;9:406-26 https://dx.doi.org/10.20517/jtgg.2025.108 Page 426

Front Pharmacol. 2022;13:884548. DOI PubMed PMC
114. Jadamba E, Shin M. A systematic framework for drug repositioning from integrated omics and drug phenotype profiles using
pathway-drug network. Biomed Res Int. 2016;2016:7147039. DOI PubMed PMC
115. Fuzo CA, Martins RB, Fraga-Silva TFC, et al. Drug repurposing to face Covid-19: Celastrol, a potential leading drug capable of
inhibiting SARS-CoV-2 replication and induced inflammation. bioRxiv. 2021;bioRxiv:2021.04.20.439992. DOI
116. Kumar R, Khandelwal N, Chander Y, et al. Emetine as an antiviral agent suppresses SARS-CoV-2 replication by inhibitinginteraction
of viral mRNAwith eIF4E: an in vitro study. bioRxiv. 2020;bioRxiv:2020.11.29.401984. DOI
117. Wang X, Li M, Yin J, et al. Emetine dihydrochloride alleviated radiation-induced lung injury through inhibiting EMT. J Cell Mol
Med. 2023;27:3839-50. DOI
118. Akinboye E. Biological activities of emetine. Open Nat Prod J. 2011;4:8-15. DOI
119. Savva K, Zachariou M, Bourdakou MM, Dietis N, Spyrou GM. Network-based stage-specific drug repurposing for Alzheimer’s
disease. Comput Struct Biotechnol J. 2022;20:1427-38. DOI PubMed PMC
120. Wang Y, Li C, Gu J, et al. Celastrol exerts anti-inflammatory effect in liver fibrosis via activation of AMPK-SIRT3 signalling. J Cell
Mol Med. 2020;24:941-53. DOI
121. Petrillo S, Pelosi L, Piemonte F, et al. Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway. Hum
Mol Genet. 2017;26:2781-90. DOI
122. Messina S, Vita GL, Aguennouz M, et al. Activation of NF-κB pathway in Duchenne muscular dystrophy: relation to age. Acta Myol.
2011;30:16-23. PubMed PMC
123. Donovan J, Elvire Vandenborne KH, Sweeney L, et al. Move DMD results: effects of edasalonexent, an NF-kB inhibitor, in 4 to 7
year old patients with Duchenne Muscular dystrophy (P3.210). Neurology. 2017;88:P3.210. DOI
124. Pinna GF, Fiorucci M, Reimund JM, Taquet N, Arondel Y, Muller CD. Celastrol inhibits pro-inflammatory cytokine secretion in
Crohn’s disease biopsies. Biochem Biophys Res Commun. 2004;322:778-86. DOI PubMed
125. Khalili N, Karimi A, Moradi MT, Shirzad H. In vitro immunomodulatory activity of celastrol against influenza a virus infection.
Immunopharmacol Immunotoxicol. 2018;40:250-5. DOI PubMed
126. Cascão R, Vidal B, Raquel H, et al. Effective treatment of rat adjuvant-induced arthritis by celastrol. Autoimmun Rev. 2012;11:856-
62. DOI PubMed PMC
127. Trott A, West JD, Klaić L, et al. Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional
signatures of a thiol-targeted molecule. Mol Biol Cell. 2008;19:1104-12. DOI
128. Boridy S, Le PU, Petrecca K, Maysinger D. Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90
inhibitor to kill human glioblastoma cells. Cell Death Dis. 2014;5:e1216. DOI PubMed PMC